Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient

Hiba Z. Hashmi, MD; Jasleen Kaur, MD; Steven C. Stout, MD, PhD; Tyler Drake, MD

Prim Care Companion CNS Disord 2023;25(4):22cr03367

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

References (12)

Cryer PE, Axelrod L, Grossman AB, et al; Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–728. PubMed CrossRef
Khoza S, Barner JC. Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports. Int J Clin Pharm. 2011;33(3):484–492. PubMed CrossRef
Gagnon J, Lussier MT, MacGibbon B, et al. The impact of antidepressant therapy on glycemic control in Canadian primary care patients with diabetes mellitus. Front Nutr. 2018;5:47. PubMed CrossRef
Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94(3):741–745. PubMed CrossRef
True BL, Perry PJ, Burns EA. Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy. Am J Psychiatry. 1987;144(9):1220–1221. PubMed CrossRef
Singh N, Khetan A, Gupta R. Chasing the offending medication: when antidepressants lead to hypoglycemia. J Clin Psychopharmacol. 2021;41(6):698–699. PubMed CrossRef
Derijks HJ, Heerdink ER, De Koning FH, et al. The association between antidepressant use and hypoglycemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf. 2008;17(4):336–344. PubMed CrossRef
Gupta B, Shakarwal MK, Kumar A, et al. Modulation of glucose homeostasis by doxepin. Methods Find Exp Clin Pharmacol. 1992;14(1):61–71. PubMed
Chen Z, Liu X, Luo Y, et al. Repurposing doxepin to ameliorate steatosis and hyperglycemia by activating FAM3A signaling pathway. Diabetes. 2020;69(6):1126–1139. PubMed CrossRef
Chang GR, Hou PH, Yang WC, et al. Doxepin exacerbates renal damage, glucose intolerance, nonalcoholic fatty liver disease, and urinary chromium loss in obese mice. Pharmaceuticals (Basel). 2021;14(3):267. PubMed CrossRef
Green AJ, Fox KM, Grandy S; SHIELD Study Group. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;96(3):313–318. PubMed CrossRef
Wredling RA, Theorell PG, Roll HM, et al. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care. 1992;15(4):518–521. PubMed CrossRef